CytomX Therapeutics
CTMX
#9609
Rank
โ‚ฌ43.59 M
Marketcap
0,54ย โ‚ฌ
Share price
-1.34%
Change (1 day)
-71.61%
Change (1 year)

Operating Margin for CytomX Therapeutics (CTMX)

Operating Margin as of March 2025 (TTM): 23.23%

According to CytomX Therapeutics 's latest financial reports and stock price the company's current Operating Margin is 23.23%. At the end of 2024 the company had an Operating Margin of 23.24%.

Operating Margin history for CytomX Therapeutics from 2015 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
202423.24%607.81%
20233.28%-101.76%
2022-186.82%-39.84%
2021-310.54%169.9%
2020-115.06%-76.77%
2019-495.32%319.24%
2018-118.15%94.03%
2017-60.89%-84.45%
2016-391.67%-14.59%
2015-458.56%-23.17%
2014-596.81%-64.98%
2013-1,704.17%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.